Description
Pain Management Conference
Saturday, January 25, 2025
Scratching the Surface: A Review of Pain Pathophysiology and
Pharmacology
8:00-9:30am
Satya Yaramati, PharmD, PGY2 Pain & Palliative Care Pharmacy Resident, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Describe
the pathophysiology of nociceptive, neuropathic, and central pain;
Collect a detailed pain history and appropriately assess a patient’s pain;
Summarize the indications, mechanism of action, dosing, side effects and
clinical pearls for various agents used to treat pain; Identify opportunities
for intervention regarding pharmacologic pain management therapy.
UAN: 0675-0000-25-001-L08-P
Recognizing the Danger Zone: Strategies and Considerations in Adjusting
Pain Management Treatment Regimens in Chronic Pain Management
9:30-11:00am
Robin Moorman Li, PharmD, BCACP, NBC-HWC, Assistant Director Jacksonville Campus, Clinical Associate Professor, University of Florida,
College of Pharmacy
Upon completion of this activity, pharmacists will be able to: Outline
common steps to create a comprehensive pain management plan; Describe
reasons why commonly used analgesic regimens must be adjusted due to
patient related and agent related variables; Recommend adjustments to
pain management treatment regimens in organ dysfunction; Demonstrate a
stepwise approach for opioid conversions; List important patient education
points on opioid conversions and proper use of breakthrough pain
medications.
UAN: 0675-0000-25-002-L08-P*
A Novel Approach: Preventing & Treating Chronic Pain Due to
Obesity in the Healthcare Setting
11:15-12:45pm
Matthew Hermenau, PharmD, CPT, NBC-HWC, Inpatient Pain Stewardship
Clinical Pharmacist, Jackson Memorial Hospital
Upon completion of this activity, pharmacists will be able to: Explain the
rising correlation between degenerative joint disease, obesity, and chronic
pain in the United States; Compare the current pitfalls of the healthcare model
for chronic pain due to obesity, and introduce a new hybrid model of inpatient
and outpatient management; Identify non-pharmacologic ways to combat the
obesity crisis and subsequent chronic pain
UAN: 0675-0000-25-003-L08-P
Managing Pain in Multiple Sclerosis
12:45-2:15pm
Lillian Smith, PharmD, MDA, CPh Associate Professor of Pharmacy Practice,
FAMU College of Pharmacy
Upon completion of this activity, pharmacists will be able to: Define
Multiple Sclerosis (MS) and its current impact within the United States;
Provide an overview of the risk factors and pathophysiology associated with
MS; Identify the potential genetic, environmental, and infectious factors that
may causes the disease state; Distinguish between the primary, secondary,
and tertiary symptoms caused by multiple sclerosis; Discuss the criterion and
physical assessment involved in concluding the diagnosis of MS; Categorize
the four types of multiple sclerosis while understanding the differences
and similarities between them; Outline both non-pharmacological and
pharmacological interventions currently available for the treatment of the
disease; Illustrate health disparities and barriers to care MS patients currently
experience in maintaining the condition; Describe the role of all involved in the
management of MS while outlining potential resources utilized for additional
support.
0675-0000-25-004-L01-P*
Sunday, January 26, 2025
The Role of the Pharmacist in Palliative Care
8:00-9:30am
Katie Maples, PharmD, Pain and Palliative Care Coordinator and Opioid
Stewardship Pharmacist, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Define
Palliative Care; Discuss the importance of defining goals of care throughout the
disease process; Recommend symptom management medication frequently
used at end of life; Identify common misconceptions related to medication
usage at end of life.
UAN: 0675-0000-25-006-L08-P
When Aging Isn’t So Fun: Pain Management, Polypharmacy and
Deprescribing in the Elderly
9:30-11:00am
Paige Broccio, PharmD, BCPS, Clinical Pharmacy Specialist, Pain Management and Palliative Care
Upon completion of this activity, pharmacists will be able to: Describe
pharmacologic difference in the elderly population; Compare multimodal
pain management options in the elderly; Discuss potential ramifications of
polypharmacy; Assess potentially inappropriate medications in the elderly
population; Determine goals of deprescribing.
UAN: 0675-0000-25-007-L08-P*
Overview of Buprenorphine
11:15-12:45pm
Taylor Bunn PharmD, PGY-1 Pharmacy Resident, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Describe the
mechanism of action, formulations, and usual doses of buprenorphine; Display
areas of pharmacy interventions; Evaluate the effects of pharmacist managed
micro-induction; Review customized buprenorphine micro-inductions;
Showcase the beneficial effects for patients.
UAN: 0675-0000-25-008-L0-P*
Abnormal Urine Drug Screen: What’s Next?
12:45-2:15pm
Joseph Cammilleri, Pharm.D,. BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain and Palliative Care Program Director, UF Clinical Assistant Professor, UF Health Jacksonville
Upon completion of this activity, pharmacists will be able to: Describe
common urine drug testing methods; Assess strategies for managing abnormal
results; Develop a strategy for tapering off opioid medications; Explain how to
transition a patient to buprenorphine.
UAN: 0675-0000-25-009-L08-P*
C = Consultant CPE G = General Pharmacist
